Adalimumab is the first entirely human monoclonal antibody (against the tumor necrosis factor , TNF ). Adalimumab is used for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn’s disease.
Active pharmaceutical ingredient
The pharmaceutically effective component of a drug (also API).
German Pharmaceutical Market Restructuring Act, which became effective as of January 1, 2011.
Permission under drug laws to market a drug in a national market.
On the pharmaceutical market: control of equipment and documentation of manufacturers or their suppliers.
Economic Optimization of Pharmaceutical Care Act; took effect in Germany on May 1, 2006.